Looking to publish in European Neuropsychopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginEuropean Neuropsychopharmacology is the official journal of the European College of Neuropsychopharmacology and focuses on clinical and basic science contributions that advance understanding of brain function and human behaviour, with emphasis on translating neuroscience and genomics findings into improved psychiatric treatments and public health impact.
Looking to publish in European Neuropsychopharmacology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
European Neuropsychopharmacology accepts the following article types. Click on an article type to view submission instructions.
Full Length Research Papers
Reviews On Specialised Topics
Short Communications
Letters To The Editor
Insights Papers
Recent Publications
Long-term outcomes of childhood ADHD stimulant use trajectories
Noa E. van der Plas, Siri D.S. Noordermeer, Catharina A. Hartman, Pieter J. Hoekstra, Nanda N.J. Rommelse, Emma Sprooten, Jaap Oosterlaan, Marjolein Luman
Erratum to “Long-term treatment with esketamine nasal spray in patients with treatment resistant depression: Results from the ESCAPE-LTE study” [European Neuropsychopharmacology 107 (2026) 112801]
A Reif, Yağcıoğlu AE Anıl, I Bitter, J Buyze, R Frey, DJ Fu, Y Godinov, L Haggström, Y Kambarov, RE Nielsen, AJ Oliveira-Maia, C von Holt, AH Young, WJ Cubała
Global patterns of clozapine prescribing: An international comparison of prescribing indications across 15 regions
Ita Fitzgerald, Sarah O’Dwyer, Ciara Ní Dhubhlaing, Siobhan Gee, Laura J. Sahm, Amanda Wheeler, Grainne Donohue, Veenu Gupta, Jo Howe, Christoph U Correll, Mikkel Højlund
Cognitive reserve beyond ageing and dementia: A framework for early psychosis prevention and intervention
Rosa Ayesa-Arriola, Elena de la Serna, Inmaculada Baeza, Israel Contador, Yaakov Stern
Corrigendum to “T70. Genetics of treatment resistant depression in Pakistan; update from the DIVERGE study” [European Neuropsychopharmacology 87, Supplement 1 (2024) 191]
Muhammad Umar, Arsalan Hassan, Fahad Hussain, Bakht Khizar, Inzemam Khan, Elvira Bramon, Glyn Lewis, Muhammad Ayub, Karoline Kuchenbaecker
Frequently asked questions
How long does it take to publish?
45 days from submission to decision after review; 33 days from submission to acceptance.
Reformat to European Neuropsychopharmacology using Livewrite PremiumIs a cover letter required?
A covering letter must accompany all submissions.
Reformat to European Neuropsychopharmacology using Livewrite PremiumWhat are the publication costs?
USD 3000 excl. taxes for open access articles; no open access publication fee for subscription articles.
Reformat to European Neuropsychopharmacology using Livewrite Premium